Eastern Asia: Vaccine Market 2024

Vaccine Market Size in Eastern Asia

The East Asian vaccine market soared to $X in 2022, rising by X% against the previous year. The total consumption indicated a tangible increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Vaccine Production in Eastern Asia

In value terms, vaccine production rose remarkably to $X in 2022 estimated in export price. The total production indicated a resilient increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2020 with an increase of X%. As a result, production attained the peak level of $X. From 2021 to 2022, production growth remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Vaccine Exports

Exports in Eastern Asia

In 2022, after three years of growth, there was significant decline in shipments abroad of vaccines for human medicine, when their volume decreased by X% to X tons. In general, exports, however, saw a measured expansion. The growth pace was the most rapid in 2021 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons, and then fell dramatically in the following year.

In value terms, vaccine exports declined significantly to $X in 2022. Overall, exports, however, saw resilient growth. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. As a result, the exports reached the peak of $X, and then shrank markedly in the following year.

Exports by Country

China represented the main exporter of vaccines for human medicine in Eastern Asia, with the volume of exports accounting for X tons, which was near X% of total exports in 2022. South Korea (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by Taiwan (Chinese) (X%), Hong Kong SAR (X%) and Japan (X%).

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Taiwan (Chinese) (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, China ($X) remains the largest vaccine supplier in Eastern Asia, comprising X% of total exports. The second position in the ranking was held by South Korea ($X), with a X% share of total exports. It was followed by Japan, with an X% share.

In China, vaccine exports expanded at an average annual rate of X% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: South Korea (X% per year) and Japan (X% per year).

Export Prices by Country

In 2022, the export price in Eastern Asia amounted to $X per ton, reducing by X% against the previous year. Overall, the export price, however, saw a resilient expansion. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. As a result, the export price reached the peak level of $X,978 per ton, and then shrank rapidly in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Japan ($X,132 per ton), while Hong Kong SAR ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced more modest paces of growth.

Vaccine Imports

Imports in Eastern Asia

In 2022, after three years of growth, there was significant decline in purchases abroad of vaccines for human medicine, when their volume decreased by X% to X tons. In general, imports, however, posted a remarkable increase. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. As a result, imports attained the peak of X tons, and then shrank notably in the following year.

In value terms, vaccine imports declined markedly to $X in 2022. Overall, imports, however, showed a significant expansion. The most prominent rate of growth was recorded in 2021 with an increase of X%. As a result, imports attained the peak of $X, and then fell markedly in the following year.

Imports by Country

China was the major importing country with an import of about X tons, which reached X% of total imports. It was distantly followed by Taiwan (Chinese) (X tons), South Korea (X tons), Japan (X tons) and Hong Kong SAR (X tons), together comprising a X% share of total imports.

China was also the fastest-growing in terms of the vaccines for human medicine imports, with a CAGR of X% from 2012 to 2022. At the same time, Taiwan (Chinese) (X%) and Hong Kong SAR (X%) displayed positive paces of growth. South Korea experienced a relatively flat trend pattern. By contrast, Japan (X%) illustrated a downward trend over the same period. China (X p.p.) and Taiwan (Chinese) (X p.p.) significantly strengthened its position in terms of the total imports, while Hong Kong SAR, South Korea and Japan saw its share reduced by X%, X% and X% from 2012 to 2022, respectively.

In value terms, the largest vaccine importing markets in Eastern Asia were China ($X), Japan ($X) and South Korea ($X), with a combined X% share of total imports.

China, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Eastern Asia amounted to $X per kg, with a decrease of X% against the previous year. In general, the import price, however, recorded buoyant growth. The pace of growth appeared the most rapid in 2021 when the import price increased by X%. As a result, import price reached the peak level of $X per kg, and then declined modestly in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Japan ($X per kg), while Hong Kong SAR ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Japan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :